Cyclin T1 and cdk9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells

Journal of Virology

Volumn 87, Issue 2, 2013, Pages 1211-1220

  Budhiraja, Sona ^a   Famiglietti, Marylinda ^b,c   Bosque, Alberto ^b   Planelles, Vicente ^b,c   Rice, Andrew P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

7SK RIBONUCLEOPROTEIN; ANTIGEN P24; CELL PROTEIN; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; MESSENGER RNA; MICRORNA; MICRORNA 150; PROTEIN HEXIM1; RIBONUCLEOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR P TEFB; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL MODEL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LATENTLY INFECTED RESTING MEMORY CD4+ T LYMPHOCYTE; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; T LYMPHOCYTE ACTIVATION; UNINFECTED RESTING MEMORY CD4+ T LYMPHOCYTE; VIRUS LATENCY;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLIN T; CYCLIN-DEPENDENT KINASE 9; GENE EXPRESSION; HIV-1; HUMANS; PHOSPHORYLATION; VIRUS LATENCY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871977941     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02413-12     Document Type: Article

References (55)

1. Chun TW, Davey RT, Jr, Engel D, Lane HC, Fauci AS. 1999. Reemergence of HIV after stopping therapy. Nature 401:874-875.
2. Fischer M, Hafner R, Schneider C, Trkola A, Joos B, Joller H, Hirschel B, Weber R, Gunthard HF. 2003. HIV RNA in plasma rebounds within days during structured treatment interruptions. AIDS 17:195-199.
3. Blankson JN, Persaud D, Siliciano RF. 2002. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:557-593.
4. Siliciano RF, Greene WC. 2011. HIV latency. Cold Spring Harb. Perspect. Med. 1:a007096. doi:10.1101/cshperspect.a007096.
5. Coiras M, Lopez-Huertas MR, Perez-Olmeda M, Alcami J. 2009. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat. Rev. Microbiol. 7:798-812.
6. Karn J, and Stoltzfus CM. 2012. Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb. Perspect. Med. 2:a006916. doi:10.1101/cshperspect.a006916.
7. He G, Margolis DM. 2002. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol. Cell. Biol. 22:2965-2973.
8. Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E. 2009. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 5:e1000495. doi:10.1371/journal.ppat.1000495.
9. Pearson R, Kim YK, Hokello J, Lassen K, Friedman J, Tyagi M, Karn J. 2008. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J. Virol. 82:12291-12303.
10. + cells is due to epigenetic transcriptional silencing and PTEFb restriction. J. Virol. 84:6425-6437.
11. + T lymphocytes. J. Virol. 86: 3244-3252.
12. + T lymphocytes. Nat. Med. 13:1241-1247.
13. + T cells. PLoS Pathog. 2:e68. doi:10.1371/journal.ppat.0020068.
14. Ott M, Geyer M, Zhou Q. 2011. The control of HIV transcription: keeping RNA polymerase II on track. Cell Host Microbe 10:426-435.
15. Yamaguchi Y, Takagi T, Wada T, Yano K, Furuya A, Sugimoto S, Hasegawa J, Handa H. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97:41-51.
16. Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH. 1997. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:2622-2632.
17. He N, Liu M, Hsu J, Xue Y, Chou S, Burlingame A, Krogan NJ, Alber T, Zhou Q. 2010. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol. Cell 38:428-438.
18. Sobhian B, Laguette N, Yatim A, Nakamura M, Levy Y, Kiernan R, Benkirane M. 2010. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol. Cell 38:439-451.
19. Peterlin BM, Price DH. 2006. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 23:297-305.
20. Garber ME, Wei P, KewalRamani VN, Mayall TP, Herrmann CH, Rice AP, Littman DR, Jones KA. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:3512-3527.
21. Pavletich NP. 1999. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287:821-828.
22. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
23. Price DH. 2008. Poised polymerases: on your markget setgo Mol. Cell 30:7-10.
24. He N, Jahchan NS, Hong E, Li Q, Bayfield MA, Maraia RJ, Luo K, Zhou Q. 2008. A La-related protein modulates 7SK snRNP integrity to suppress P-TEFb-dependent transcriptional elongation and tumorigenesis. Mol. Cell 29:588-599.
25. Nguyen VT, Kiss T, Michels AA, Bensaude O. 2001. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414:322-325.
26. Yik JH, Chen R, Nishimura R, Jennings JL, Link AJ, Zhou Q. 2003. Inhibition of P-TEFb (CDK9/cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol. Cell 12:971-982.
27. Krueger BJ, Varzavand K, Cooper JJ, Price DH. 2010. The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK. PLoS One 5:e12335. doi:10.1371/journal.pone.0012335.
28. Michels AA, Fraldi A, Li Q, Adamson TE, Bonnet F, Nguyen VT, Sedore SC, Price JP, Price DH, Lania L, Bensaude O. 2004. Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor. EMBO J. 23:2608-2619.
29. + T cells and inhibits HIV-1 gene expression. Retrovirology 9:52.
30. Ramakrishnan R, Dow EC, Rice AP. 2009. Characterization of Cdk9 T-loop phosphorylation in resting and activated CD4(+) T lymphocytes. J. Leukoc. Biol. 86:1345-1350.
31. Larochelle S, Amat R, Glover-Cutter K, Sanso M, Zhang C, Allen JJ, Shokat KM, Bentley DL, Fisher RP. 2012. Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat. Struct. Mol. Biol. 19:1108-1115.
32. + T lymphocytes and macrophages. Curr. HIV Res. 1:395-404.
33. +) T lymphocytes by combination of cytokines. J. Virol. 75:11336-11343.
34. Hoque M, Shamanna RA, Guan D, Pe'ery T, Mathews MB. 2011. HIV-1 replication and latency are regulated by translational control of cyclin T1. J. Mol. Biol. 410:917-932.
35. Liou LY, Herrmann CH, Rice AP. 2004. Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages. J. Virol. 78:8114-8119.
36. + T cells. Blood 113:58-65.
37. Bosque A, Planelles V. 2011. Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells. Methods 53:54-61.
38. + T cells. Retrovirology 3:66.
39. + T cells. PLoS Pathog. 7:e1002288. doi:10.1371/journal.ppat.1002288.
40. Wang Y, Rice AP. 2006. Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis. Virology 352:485-492.
41. Yang Z, Zhu Q, Luo K, Zhou Q. 2001. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 414: 317-322.
42. + T cells can produce HIV Gag without spreading infection in a model of HIV latency. PLoS Pathog. 8:e1002818. doi:10.1371/journal.ppat.1002818.
43. + T cells. Retrovirology 8:80.
44. Karn J. 2011. The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit. Curr. Opin. HIV AIDS 6: 4-11.
45. Ramakrishnan R, Rice AP. 2012. Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway. J. Cell. Physiol. 227:609-617.
46. Colin L, Van Lint C. 2009. Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 6:111.
47. Contreras X, Barboric M, Lenasi T, Peterlin BM. 2007. HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription. PLoS Pathog. 3:1459-1469.
48. Chen R, Yang Z, Zhou Q. 2004. Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. J. Biol. Chem. 279:4153-4160.
49. Haaland RE, Herrmann CH, Rice AP. 2003. Increased association of 7SK snRNA with Tat cofactor P-TEFb following activation of peripheral blood lymphocytes. AIDS 17:2429-2436.
50. Barboric M, Yik JH, Czudnochowski N, Yang Z, Chen R, Contreras X, Geyer M, Matija Peterlin B, Zhou Q. 2007. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Res. 35:2003-2012.
51. Dow EC, Liu H, Rice AP. 2010. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes. J. Cell. Physiol. 224:84-93.
52. Micheva-Viteva S, Kobayashi Y, Edelstein LC, Pacchia AL, Lee HL, Graci JD, Breslin J, Phelan BD, Miller LK, Colacino JM, Gu Z, Ron Y, Peltz SW, Dougherty JP. 2011. High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor. J. Biol. Chem. 286:21083-21091.
53. + T cell model without inducing global T cell activation. J. Virol. 85:6060-6064.
54. Yang HC, Shen L, Siliciano RF, Pomerantz JL. 2009. Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proc. Natl. Acad. Sci. U. S. A. 106:6321-6326.
55. Garriga J, Peng J, Parreno M, Price DH, Henderson EE, Grana X. 1998. Upregulation of cyclin T1/CDK9 complexes during T cell activation. Oncogene 17:3093-3102.